ZA77248B - Piperazine derivatives - Google Patents

Piperazine derivatives

Info

Publication number
ZA77248B
ZA77248B ZA770248A ZA77248A ZA77248B ZA 77248 B ZA77248 B ZA 77248B ZA 770248 A ZA770248 A ZA 770248A ZA 77248 A ZA77248 A ZA 77248A ZA 77248 B ZA77248 B ZA 77248B
Authority
ZA
South Africa
Prior art keywords
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
ZA770248A
Other languages
English (en)
Inventor
R Cyhrus
M Raschack
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA77248B publication Critical patent/ZA77248B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA770248A 1976-02-07 1977-01-17 Piperazine derivatives ZA77248B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
ZA77248B true ZA77248B (en) 1977-11-30

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA770248A ZA77248B (en) 1976-02-07 1977-01-17 Piperazine derivatives

Country Status (25)

Country Link
US (1) US4079137A (de)
JP (1) JPS52105186A (de)
AT (1) AT355578B (de)
AU (1) AU504526B2 (de)
BE (1) BE850492A (de)
CA (1) CA1094560A (de)
CH (1) CH631448A5 (de)
CS (1) CS201544B2 (de)
DD (1) DD128133A5 (de)
DE (1) DE2604845A1 (de)
DK (1) DK138891C (de)
ES (1) ES455691A1 (de)
FI (1) FI63226C (de)
FR (1) FR2340311A1 (de)
GB (1) GB1550545A (de)
HU (1) HU173483B (de)
IE (1) IE44339B1 (de)
IL (1) IL51316A (de)
LU (1) LU76706A1 (de)
NL (1) NL7700841A (de)
NO (1) NO142625C (de)
PL (1) PL105526B1 (de)
PT (1) PT66154B (de)
SE (1) SE7701187L (de)
ZA (1) ZA77248B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
CN101072582B (zh) 2004-12-06 2012-06-27 赛生制药有限公司 作为癌症疫苗佐剂的α胸腺肽
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
CA2709027A1 (en) * 2007-12-12 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)
JP2011506473A (ja) * 2007-12-13 2011-03-03 サイクローン・ファーマシューティカルズ・インコーポレイテッド キナーゼ阻害剤と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法
JP2011506467A (ja) * 2007-12-14 2011-03-03 サイクローン・ファーマシューティカルズ・インコーポレイテッド 抗悪性腫瘍性熱ショックアポトーシス活性化因子（ｈｓａａ）と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
EP2427213B1 (de) * 2009-05-08 2015-04-01 Sciclone Pharmaceuticals, Inc. Alpha-thymosin-peptide als impfstoffverstärker
EP3943101A1 (de) 2014-10-21 2022-01-26 SciClone Pharmaceuticals International Ltd. Behandlung von krebs mit immunstimulator alpha-thymosin peptid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines

Also Published As

Publication number Publication date
NO142625C (no) 1980-09-17
FR2340311A1 (fr) 1977-09-02
CS201544B2 (en) 1980-11-28
JPS52105186A (en) 1977-09-03
IE44339B1 (en) 1981-10-21
NL7700841A (nl) 1977-08-09
SE7701187L (sv) 1977-08-08
FI63226B (fi) 1983-01-31
ES455691A1 (es) 1978-01-01
GB1550545A (en) 1979-08-15
DD128133A5 (de) 1977-11-02
ATA68177A (de) 1979-08-15
DK49077A (da) 1977-08-08
FI63226C (fi) 1983-05-10
NO770374L (no) 1977-08-09
PT66154B (fr) 1978-07-07
AU2195277A (en) 1978-08-10
AT355578B (de) 1980-03-10
AU504526B2 (en) 1979-10-18
HU173483B (hu) 1979-05-28
DK138891C (da) 1979-04-23
PT66154A (fr) 1977-03-01
IL51316A0 (en) 1977-03-31
CA1094560A (en) 1981-01-27
NO142625B (no) 1980-06-09
CH631448A5 (de) 1982-08-13
IE44339L (en) 1977-08-07
FI770398A7 (de) 1977-08-08
IL51316A (en) 1980-12-31
US4079137A (en) 1978-03-14
FR2340311B1 (de) 1980-02-08
LU76706A1 (de) 1977-06-28
PL105526B1 (pl) 1979-10-31
DE2604845A1 (de) 1977-08-18
BE850492A (fr) 1977-07-18
DK138891B (da) 1978-11-13

Similar Documents

Publication Publication Date Title
NZ185971A (en) Morpholine derivatives
JPS5612375A (en) Morpholine derivative
GB1545094A (en) Piperazine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
IL51316A0 (en) Piperazine derivatives
NZ183715A (en) Phenylpiperazine derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
GB1554517A (en) Nogarol derivatives
AU513087B2 (en) l-Substituted-4-fusedbenzyl piperazine derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1549755A (en) N-4-halobutyryl derivatives
IL52270A0 (en) Hydrazinopyridazine derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
GB1550544A (en) Alkylenedioxybenzyl piperazine derivatives
JPS52100431A (en) Anilinoacetate derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
GB1550656A (en) Morpholine derivatives
ZA772148B (en) Substituted piperazine derivatives
AU2536577A (en) 2-nitroindandione derivatives
GB1544289A (en) Thiazolinotriazine derivatives
JPS5283696A (en) Cephalospoline derivatives